NRSNW
NeuroSense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.05
−8.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.73x
- Price / sales
- —
- Price / cash flow
- -0.31x
Enterprise value
- Enterprise value
- $1.1M
- EV / sales
- —
- EV / EBITDA
- -0.10x
- EV / EBIT
- -0.10x
- Market cap
- $1.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025